WITH THE TECHNICAL ASSISTANCE OF AARON J. BLUMBERG( Setial measurements of the bo(ly weight and the exchangeable sodium content were made in young pjatieIlts with acute lheumatic fever who weie being tieated with laige (loses of corticotropin. All lut one subject developed the clinical signs of hyperadrenalism. Eight of the 11 subjects showed at least a 20 per cent increase in body weight which could not be explained on the basis of the changes in exchangeable sodium content. This change in body composition is thought to be due primariily to an increase in total body fat.
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TILE prolonged administration of cor- ticotropin (ACTH) in therapeutic doses is known to produce the physical signs of hyperadrenalism. 1 The increase in body weight resulting from such administration has usually been attributed in large measure to retention and redistribution of sodium and water. This explanation appears to be reasonable inl adults, since a decrease in body weight and rapid excretion of sodium often follows the administration of a diuretic agent or the discontinuance of corticotropin.A The "moon facies"' and the "buffalo hump" observed clinically, however, suggest a more profound change in body composition. To date few studies on the effects of ACTH on fat metabolism have been reported. 4' In the course of a study on the immuinophysiology of rheumatic fever, it became apparent that rheumatic children and adolescents who gained weight while being treated with ACTH did not respond with diuresis when mercurial diuretics were given. The purpose of the present report is to =Nai24 -Na-U24
Na-e -Na-s24/Na-_23 Na-e = quantity of exchangeable sodium in milliequivalents (mEq.). Na-i24 = quantity of radiosodium administered (arbitrary units). Na-u24 = quantity of radiosodium excreted in the pooled specimen of urine. Na-s24 = concentration of radiosodium in the serum at 24 hours. Na-s23 = concentration of nonradioactive sodium in the serum at 24 hours.
Na-s24/Na-s23 = specific activity of the serum at 24 hours. Preliminary studies in this laboratory revealed that the Na-e measurement was reproducible within five per cent in hospitalized subjects who were convalescing from various diseases." This finding agrees with those previously reported by M\liller and Wilson.9
A total of 53 determinations of exchangeable sodium content were made; a minimum of three and a maximum of seven serial determinations were performed on each subject, usually at intervals of two to three weeks. Each patient was observed for a minimum of 50 days.
Measurement of Radioactivity. The radioactivity of the urine and serum specimens was determined with a well-type scintillation counter and a scaling circuit. A total of 10,000 counts were made on each sample. All determinations were corrected for decay of the isotope. The total sodium concentration in the serum was determined with a Baird flame photometer, using the lithium internal standard method.
RESULTS (table 1) Signs of hyperadrenalism. All subjects except one (case 9) showed obvious clinical signs of hyperadrenalism, moon face, cervical and supraclavicular fat pads (buffalo hump) and acne, while being treated with corticotropin.
In case 9 some fullness of the face developed by the fourth week of corticotropin therapy, but there were no other obvious manifestations.
No relationship between the development of hyperadrenalism and the effect of corticotropin on the underlying rheumatic process was observed.
Changes in Body Weight ( fig. 1 ). In nine of the 11 subjects the body weight increased by at least 10 per cent (cases 1 to 9). In five of these individuals (cases 1, 2, 3, 5 and 6) the weight gain was more than 25 per cent! of the initial value. The greatest rate of increase was observed in the individual (case 1) who received the largest daily dosage of corticotropin (5.7 units per Kg.); on the seventy-fifth and eightyninth day, this patient's weight was 65 per cent above the original measurement,. Twro subjects (cases 10 and 11), although they showed the clinical signs of Cushingys syndrome, failed to gain weight.
Although there was considerable variability, the increase in body weight appeared to be progressive and related to the dosage and the duration of therapy. There was no definite relationship between the changes in body weight and the effect of corticotropin on the rheumatic process.
Changes in Exchangeable Sodium Content (Na-e) ( fig. 2 ). Five subjects (cases 1, 5, 6, 7, and 11) revealed at least, a 10 per cent increase in the exchangeable sodium content at, some time during the period of observation. In two of these individuals, this increase was observed after treatment*with corticotropin was discontinued. In the other three individuals, subsequent values for exchangeable sodium content obtained while the subjects were being treated with corticotropin were equal to the baseline values, or e-en lower.
In the other six individuals no significant increase in the exchangeable sodium content was demonstrated during corticotropin therapy. In three instances (cases 2, 3 and 4) exchangeable sodium contents 29, 22 and 21 per cent below the initial determinations were obtained while the patients were on corticotropin therapy and while body weight was increasing. (2) Although it has been previously suggested10 that the gain in weight not explained by changes in nitrogen, sodium or potassium may be a Pitressin effect, the lack of diuresis and weight loss on discontinuation of therapy argues against this possibility. Were this simply a retention of water due to an antidiuretic effect, the serum sodium concentration should have fallen.
(3) Although the administration of corticotropin usually results in negative nitrogen and potassium balance, positive nitrogen balance may occur, provided the dietary intake is great enough,1' and children and adolescents on Acthar gel do have enormous appetites. Therefore, the discrepancy between the increase in body weight and the changes in exchaiigeable sodium contents can be attributed to an increase in nonextracellular body tissue. While it is recognized that these changes may in part be the effects of normal body growth, it is difficult to explain all of them solely on this basis. In two subjects (cases 10 there is no change in intracellular osmnolarity, then an unchamiged total exchangeable sodium, which includes intracellular sodium, with ali increase in body weight would iieamii that the increase in intracellular fluid would have been due primarily to an increase inl potassium. This certainly would not be in the expected direction in patients receiving corti cotropill.
The increase in serumn concentration of sodium during corticotropi n therapy suggests that a redistribution of water into the initiracellular phase may have occurred. Suich a change could occur as a result of a large change in osmolarity of intracellular solutes or cations. However, the only way in which this intracellular water increase could occur would be by a positive balance of potassium; this would be unlikely during corticotropin therapy. Deane and his co-workers'2 have reported that, in one of two patients with acute rheumatic fever treated with corticotropin, 100 mg. daily for 34 days, the body weight in(Teased progressively from 53.9 to 60.0 Kg. The exchangeable sodium content remained comistant,h but the total water content increased progressiv ely. These data suggest that the intracellular water content was increased. Howev-er, it is difficult to explain increases of 25 
